Intest Res.
2025 Jul;23(3):229-230. 10.5217/ir.2025.00114.
Upadacitinib after tofacitinib in ulcerative colitis
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
- KMID: 2570916
- DOI: http://doi.org/10.5217/ir.2025.00114
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in Japan
- Optimizing Janus kinase inhibitor therapy for ulcerative colitis: a real-world perspective
- Optimal use and cycling strategies of Janus kinase inhibitors in ulcerative colitis: current evidence and clinical implications from the KASID Guidelines Task Force Team
- Effects of Dextran Sulfate Sodium-Induced Ulcerative Colitis on the Disposition of Tofacitinib in Rats
- Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study
